PLoS ONE · 2007 · 41 citations · 50 references
Life SciencesImmunologyInfectious DiseasesImmunology Of Infectious DiseasesMolecular VirologyVirologyAnimal VirusesAntiviral ImmunityHumoral ImmunityImmunoglobulin FunctionViral Immune EvasionViral InfectionsAnti-viral ImmunityAntibody-mediated Viral NeutralizationAntibody-mediated Virus NeutralizationAntigenic Variation In VirusesGlycoprotein FunctionNeutralizationViral Antigen RecognitionViral Glycoproteins
Herpesviruses maintain long-term infectivity without marked antigenic variation. They must therefore evade neutralization by other means. Immune sera block murine gammaherpesvirus-68 (MHV-68) infection of fibroblasts, but fail to block and even enhance its infection of IgG Fc receptor-bearing cells, suggesting that the antibody response to infection is actually poor at ablating virion infectivity completely. Here we analyzed this effect further by quantitating the glycoprotein-specific antibody response of MHV-68 carrier mice. Gp150 was much the commonest glycoprotein target and played a predominant role in driving Fc receptor-dependent infection: when gp150-specific antibodies were boosted, Fc receptor-dependent infection increased; and when gp150-specific antibodies were removed, Fc receptor-dependent infection was largely lost. Neither gp150-specific monoclonal antibodies nor gp150-specific polyclonal sera gave significant virion neutralization. Gp150 therefore acts as an immunogenic decoy, distorting the MHV-68-specific antibody response to promote Fc receptor-dependent infection and so compromise virion neutralization. This immune evasion mechanism may be common to many non-essential herpesvirus glycoproteins.
50
Complete sequence and genomic analysis of murine gammaherpesvirus 68
Herbert W. Virgin, Phil Latreille, P Wamsley et al. · Journal of Virology · 1997 · 730 citations · Full text